Table 1. Baseline characteristics of the study population.
Total study population (n = 61) | ||
---|---|---|
Age, years, mean (range) | 65 | (34–90) |
Female sex | 18 | (29.5) |
Current smoking | 22 | (37.3) |
Hypertension | 21 | (34.4) |
Dyslipidaemia | 13 | (21.3) |
Diabetes mellitus | 6 | (9.8) |
Previous MI | 11 | (18.0) |
Cardiogenic shock | 9 | (14.8) |
Multiple vessel disease on angiography | 31 | (50.8) |
IRA—Left anterior descending artery | 46 | (75.4) |
•Left circumflex artery | 8 | (13.1) |
•Right coronary artery | 3 | (4.9) |
•Left main stem | 4 | (6.6) |
WMSI at baseline | 1.98 | (± 0.23) |
GLS at baseline | -9.07 | (± 2.17) |
LVEF at baseline, % | 41.2 | (± 8.5) |
NT-proBNP, ng/L | 434 | (264, 779) |
Peak TnT, ng/L | 12 915 | (7811, 17523) |
Total leukocyte count, x109/L | 12.7 | (10.2, 15.8) |
Creatinine, μmol/L | 82 | (68, 97) |
Systolic blood pressure on admission | 104 | (± 16.3) |
Diastolic blood pressure on admission | 65 | (± 9.8) |
Hours from PCI to study infusion/baseline | 22 | (14, 29) |
Values presented as mean (±SD) or (range), median (25th, 75th percentiles) or numbers (%) as appropriate. n: Number of cases.
MI: Myocardial infarction.
IRA: Infarct-related artery.
WMSI: Wall motion score index.
GLS: Global longitudinal strain.
LVEF: Left ventricular ejection fraction.
NT-proBNP: N-terminal pro-brain natriuretic peptide.
TnT: Cardiac troponin T.
PCI: Percutaneous coronary intervention.